Trials / Recruiting
RecruitingNCT06865859
Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients
Single-cell Landscape of Immunological Responses in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (estimated)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to profile the peripheral blood immune cells of patients with HBV related acute-on-chronic liver failure using single-cell RNA sequencing to reveal the immunopathological mechanisms of HBV related acute-on-chronic liver failure.
Detailed description
Acute-on-chronic liver failure (ACLF) is a complex clinical syndrome characterized by acute deterioration of liver function in patients with chronic liver disease, exhibiting liver and extrahepatic organ failure and a high short-term mortality. Immune imbalance plays an important role in the progression of HBV-related ACLF. Further investigation of the immune cell characteristics of HBV-related ACLF is helpful to understand its pathogenesis, and may provide reference for the effective therapeutic agent. Single-cell RNA sequencing (scRNA-seq) is the quantitative analysis of transcription at the single-cell level, which could provide systematic analyses of transcriptomic profiles, infer cell-cell interactions. This study will combine single cell transcriptomics and molecular biological experiment to elucidate the immunopathological cell states associated with HBV-related chronic liver disease vs. ACLF.
Conditions
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2025-05-01
- Completion
- 2025-05-01
- First posted
- 2025-03-10
- Last updated
- 2025-03-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06865859. Inclusion in this directory is not an endorsement.